Results

Total Results: 2,166 records

Showing results for "event".

101. Methods-Guide-Chapter-Prioritization-And-Selection-Of-Harms-For-Inclusion-In-Systematic-Reviews (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/prioritization-selection-of-harms.pdf
     February 01, 2018 - adverse event,” or “any serious adverse event”; rather, the reports generally focused on specific adverse … MedWatch: The FDA Safety Information and Adverse Event Reporting Program. … What is a Serious Adverse Event? 2016. … 4) Are there general (non-specific) harms (e.g., any adverse event, any serious adverse event, withdrawal … Are there general (non-specific) harms (e.g., any adverse event, any serious adverse event, withdrawal

102. Developing and Piloting a Tool To Create Dot Plots To Summarize Pooled Data for Multiple Outcomes in Systematic Reviews (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/product/pdf/dot-plots-methods.pdf
     October 01, 2021 - plot for dichotomous outcomes, statins versus placebo or no statin Abbreviations: AE = adverse event … Liver Enzyme Abnormalities 11 200 22833 179 22103 1.10 0.90 1.35 0 High Abbreviations: AE = adverse event … 2.37 2.99 0 High Pruritus 30 710 7199 99 4255 3.51 2.47 5.16 0.5 High Abbreviations: AE = adverse event … Advantages of visualisations to evaluate and communicate adverse event information in randomised … Advantages of visualisations to evaluate and communicate adverse event information in randomised controlled

103. Radiation Therapy for Brain Metastases: A Systematic Review | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/radiation-brain-metastases/protocol
     June 01, 2021 - The broader inclusion criteria for adverse event data take into account that rare adverse events are … All analyses will consider the number of studies that assessed an adverse event and the observed events … Where studies report events for one arm, we will assume that no event occurred in the other study arm … The adverse event assessment will specifically include larger observational studies and not limit the … What is a Serious Adverse Event?  Accessed on October 10, 2019. IntHout J, Ioannidis JP, Borm GF.

104. Designing a Deliberative Forum (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/delilberative-methods-design-abelson.pdf
     January 11, 2017 - needs to be communicated clearly and often: o recruitment stage o beginning of first deliberation event

105. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/gestational-diabetes-screening-diagnosis_research-protocol.pdf
     December 16, 2011 - with an adverse event. … We will count each event as if it corresponded to a unique individual. … assumption may overestimate the number of patients that experience an adverse event. … If no event is reported in one treatment arm, a correction factor of 0.5 will be added to each cell … Summary of Protocol Amendments In the event of protocol amendments, the date of each amendment will

106. Treatment for Adults With Schizophrenia | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/schizophrenia-adult/research-2017
     February 01, 2018 - illness symptoms, negative symptoms, symptom response, and remission but greater incidence of adverse event … Older SGAs were similar to haloperidol on benefit outcomes but had fewer adverse event outcomes.

107. Cer-250-Cannabis-2024-Surv-Rep-Update-Tables-E1-4 (xls file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-tables-e1-4.xlsx
     January 01, 2024 - Adverse Event Intervention B, N of Any Adverse Event (Numerator) Intervention B, N Analyzed for Any … Event (Numerator) Intervention C, N Analyzed for Any Adverse Event (Denominator) Intervention C, % … With Any Adverse Event Intervention D, N of Any Adverse Event (Numerator) Intervention D, N Analyzed … A, % With Serious Adverse Event Intervention B, N of Serious Adverse Event (Numerator) Intervention … ) Intervention C, % With Serious Adverse Event Intervention D, N of Serious Adverse Event (Numerator)

108. Omega−3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/fatty-acids-cardiovascular-disease_executive.pdf
     August 01, 2016 - Clinical Event Outcomes, RCTs No RCTs reported clinical event outcomes for comparisons of total n-3 … Clinical Event Outcomes, RCTs Regarding clinical event outcomes, 19 trials in populations at increased … Clinical Event Outcomes, RCTs Regarding clinical event outcomes, one trial in an at risk population … Clinical Event Outcomes, RCTs No trial that reported clinical event outcomes evaluated DHA alone. … Clinical Event Outcomes, RCTs No trial that reported clinical event outcomes compared marine oil FA

109. Slide 1 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/cf_deliberativemethodswebinar_desigingdeliberativeforum.pdf
     May 18, 2012 - needs to be communicated clearly and often: – recruitment stage – beginning of first deliberation event

110. Update of Comparative Effectiveness of Lipid-Modifying Agents | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/high-cholestorol-medicines-update/research-protocol
     December 01, 2019 - adherence as defined by the study investigator SAEs as defined by the study investigator (e.g., an event … ; withdrawal due to an adverse event; cancer; serum aspartate transaminase and/or alanine aminotransferase … ; withdrawal due to an adverse event; cancer; serum AST and/or serum ALT elevated ≥3 times the ULN and … For sparse-data meta-analysis, we will employ the Peto odds ratio method when event rates are less than … When between-event rates are between 5 to 10 percent, substantial differences between the N of two arms

111. Adverse Effects of First-line Pharmacologic Treatments of Major Depression in Older Adults | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/depression-harms/research-protocol
     May 01, 2019 - and between pharmacologic classes; thus the recommendation is to choose a medication based on adverse event … Outcomes: We are interested in the following adverse effects for KQ1 and KQ2: Any adverse event, … The original full publication will always be used as the primary data source in the event discrepant … Impact of including or excluding both-armed zero-event studies on using standard meta-analysis methods … for rare event outcome: a simulation study.

112. Safety of Vaccines Used for Routine Immunization of Adults (Including Pregnant Women) and Children | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/vaccine-safety/research-protocol
     December 01, 2020 - safety, 9 including postlicensure safety surveillance conducted by the FDA, 10 the Vaccine Adverse Event … This report evaluated the scientific evidence for event-vaccine relationships and covered many vaccines … Internet-based reporting to the vaccine adverse event reporting system: a more timely and complete way … Tdap = Tetanus, diphtheria, and acellular pertussis VAERS = Vaccine Adverse Event Reporting System … Adverse events of interest, included in electronic search terms Adverse event Vaccine type

113. Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/thromboembolism-update/research-2017
     January 01, 2021 - In THR, LMWH has lower VTE and adverse event risks than unfractionated heparin; LMWH and aspirin have … In THR, LMWH has lower VTE and adverse event risks than UFH, LMWH and aspirin have similar risks of VTE

114. Dietary Saturated Fat Replacement and Plasma Lipid and Cardiovascular Events | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/saturated-fat-replacement/protocol
     November 01, 2024 - and low density lipoprotein cholesterol (LDL-c) concentration, and between LDL-c concentration and CV event … specificity and evidence-based guidance to optimize plasma lipoprotein profiles, with the goal of lowering CV event … prospectively We will aim for a minimum of about 10 observational studies for each specific intervention - CV event … acids and cardiovascular disease (https://doi.org/10.23970/AHRQEPCERTA223), we included: for cardiac event

115. Plant-Based-Treatments-Draft-Report-2025-Rct-Table-App-E (xls file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/plant-based-treatments-draft-report-2025-rct-table-app-e.xlsx
     January 01, 2025 - Adverse Event Intervention B, N of Any Adverse Event (Numerator) Intervention B, N Analyzed for Any … Event (Numerator) Intervention C, N Analyzed for Any Adverse Event (Denominator) Intervention C, % … With Any Adverse Event Intervention D, N of Any Adverse Event (Numerator) Intervention D, N Analyzed … A, % With Serious Adverse Event Intervention B, N of Serious Adverse Event (Numerator) Intervention … ) Intervention C, % With Serious Adverse Event Intervention D, N of Serious Adverse Event (Numerator)

116. Cannabis-2022-Surv-Rep-3-Table-F5 (xls file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-table-F5.xlsx
     January 01, 2022 - C % (n/N) Any adverse event 3 months: 35% (19/49) vs. 47% (30/52) vs. NR, RR for A vs. … B Total patients reporting treatment related adverse event: 21.1% (71/337) vs. 35.0% (118/337), RR 0.60 … B % (n/N) Any adverse event: 88.4% (190/215) vs. 85.2% (184/216), RR 1.02 (95% CI 0.88 to 1.18) Serious … SF-36 = short form 36 question survey; THC = tetrahydrocannabinol; TRAE = treatment related adverse event

117. Cannabis-2022-Update-Surv-Rep-1-App-F-5 (xls file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-app-F-5.xlsx
     January 01, 2022 - C % (n/N) Any adverse event 3 months: 35% (19/49) vs. 47% (30/52) vs. NR, RR for A vs. … B Total patients reporting treatment related adverse event: 21.1% (71/337) vs. 35.0% (118/337), RR 0.60 … B % (n/N) Any adverse event: 88.4% (190/215) vs. 85.2% (184/216), RR 1.02 (95% CI 0.88 to 1.18) Serious … SF-36 = short form 36 question survey; THC = tetrahydrocannabinol; TRAE = treatment related adverse event

118. Evidence Summary_Comparative Effectiveness Review No. 250_Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2022 Update (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-evidence-summary-2022-update_0.pdf
     January 01, 2022 - • Other key adverse event outcomes (psychosis, cannabis use disorder, cognitive deficits) and outcomes … ) Insufficient (1) Abbreviations: CBD = cannabidiol; CBDV = cannabidivarin; SAE = serious adverse event … ; SOE = strength of evidence; THC = tetrahydrocannabinol; WAE = withdrawal due to adverse event. … Understanding how the adverse event profiles of cannabis products compare with other available treatments … In order to better understand the small to moderate improvements in pain, and the complete adverse event

119. Register Now: April 29 Virtual Grand Rounds To Highlight Making Healthcare Safer IV Report | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/news/grand-rounds-mhs
     April 01, 2024 - Stewardship Interventions Engaging Family Caregivers Rapid Response Systems Register now for the event

120. Cannabis-2023-Surv-Rep-4-Table-E-5 (xls file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-table-E-5.xlsx
     January 01, 2023 - C % (n/N) Any adverse event 3 months: 35% (19/49) vs. 47% (30/52) vs. NR, RR for A vs. … C Any adverse event: 26.1% (91/348) vs. 14.9% (56/377); adjusted OR 1.00 (95% CI 0.64 to 1.58) NR No … B Total patients reporting treatment related adverse event: 21.1% (71/337) vs. 35.0% (118/337), RR 0.60 … B % (n/N) Any adverse event: 88.4% (190/215) vs. 85.2% (184/216), RR 1.02 (95% CI 0.88 to 1.18) Serious … SF-36 = short form 36 question survey; THC = tetrahydrocannabinol; TRAE = treatment related adverse event